These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9460526)
1. Delayed enhancement of myocardial FDG uptake on glucose loading FDG-PET in NIDDM patient. Tsuchida T; Yonekura Y; Wada Y; Sadato N; Yamamoto K; Waki A; Nakano A; Lee JD; Hayashi N; Ishii Y Ann Nucl Med; 1997 Nov; 11(4):331-4. PubMed ID: 9460526 [TBL] [Abstract][Full Text] [Related]
2. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading]. Brink I; Nitzsche EU; Mix M; Schindler T; Hentschel M; Högerle S; Moser E Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453 [TBL] [Abstract][Full Text] [Related]
3. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction. Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067 [TBL] [Abstract][Full Text] [Related]
5. Correlation between myocardial blood flow and fasting glucose metabolism in ischemic heart disease. Quantitative assessment by nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose positron emission tomography. Watanabe T; Okazaki O; Akutsu Y; Yamanaka H; Michihata T; Katagiri T; Harumi K Jpn Heart J; 1998 May; 39(3):275-85. PubMed ID: 9711179 [TBL] [Abstract][Full Text] [Related]
6. Myocardial glucose metabolism in patients with hypertrophic cardiomyopathy: assessment by F-18-FDG PET study. Uehara T; Ishida Y; Hayashida K; Shimonagata T; Miyake Y; Sago M; Oka H; Nagata S; Miyatake K; Nishimura T Ann Nucl Med; 1998 Apr; 12(2):95-103. PubMed ID: 9637280 [TBL] [Abstract][Full Text] [Related]
7. Glucose tolerance and myocardial F-18 fluorodeoxyglucose uptake in normal regions in coronary heart disease patients. Hasegawa S; Kusuoka H; Uehara T; Yamaguchi H; Hori M; Nishimura T Ann Nucl Med; 1998 Dec; 12(6):363-8. PubMed ID: 9972374 [TBL] [Abstract][Full Text] [Related]
8. Characteristics of myocardial 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy. Yamaguchi H; Hasegawa S; Yoshioka J; Uehara T; Hashimoto K; Kusuoka H; Kuzuya T; Hori M; Nishimura T Ann Nucl Med; 2000 Feb; 14(1):33-8. PubMed ID: 10770578 [TBL] [Abstract][Full Text] [Related]
10. Cardiac 18F-FDG-SPET studies in patients with non-insulin-dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping. Bax JJ; Visser FC; Raymakers PG; Van Lingen A; Cornel JH; Huitink JM; Elhendy A; Heine RJ; Visser CA Nucl Med Commun; 1997 Mar; 18(3):200-6. PubMed ID: 9106773 [TBL] [Abstract][Full Text] [Related]
11. Myocardial FDG-PET examination during fasting and glucose loading states by means of a one-day protocol. Tsuchida T; Sadato N; Yonekura Y; Sugimoto K; Nakano A; Lee JD; Takahashi N; Waki A; Ishii Y; Itoh H Ann Nucl Med; 2001 Oct; 15(5):433-8. PubMed ID: 11758948 [TBL] [Abstract][Full Text] [Related]
12. A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography. Martin WH; Jones RC; Delbeke D; Sandler MP Eur J Nucl Med; 1997 Oct; 24(10):1291-7. PubMed ID: 9323271 [TBL] [Abstract][Full Text] [Related]
13. Regional glucose utilization in infarcted and remote myocardium: its relation to coronary anatomy and perfusion. Fragasso G; Chierchia SL; Landoni C; Lucignani G; Rossetti E; Sciammarella M; Vanoli GE; Fazio F Nucl Med Commun; 1998 Jul; 19(7):625-32. PubMed ID: 9853342 [TBL] [Abstract][Full Text] [Related]
14. The influences of blood glucose and duration of fasting on myocardial glucose uptake of [18F]fluoro-2-deoxy-D-glucose. Ding HJ; Shiau YC; Wang JJ; Ho ST; Kao A Nucl Med Commun; 2002 Oct; 23(10):961-5. PubMed ID: 12352594 [TBL] [Abstract][Full Text] [Related]
15. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. Knuuti MJ; Nuutila P; Ruotsalainen U; Saraste M; Härkönen R; Ahonen A; Teräs M; Haaparanta M; Wegelius U; Haapanen A J Nucl Med; 1992 Jul; 33(7):1255-62. PubMed ID: 1613561 [TBL] [Abstract][Full Text] [Related]
16. Simple method to quantify myocardial glucose metabolism from MB ratio in myocardial FDG PET. Nishikawa J; Ohtake T; Yokoyama I; Watanabe T; Momose T; Sasaki Y Ann Nucl Med; 1996 Aug; 10(3):323-8. PubMed ID: 8883708 [TBL] [Abstract][Full Text] [Related]
17. Visceral adiposity is associated with altered myocardial glucose uptake measured by (18)FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes. Kim G; Jo K; Kim KJ; Lee YH; Han E; Yoon HJ; Wang HJ; Kang ES; Yun M Cardiovasc Diabetol; 2015 Nov; 14():148. PubMed ID: 26538247 [TBL] [Abstract][Full Text] [Related]
18. Assessment of myocardial viability with a positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET. Tian M; Koyama K; Zhang H; Oriuchi N; Higuchi T; Endo K Nucl Med Commun; 2003 Apr; 24(4):367-74. PubMed ID: 12673164 [TBL] [Abstract][Full Text] [Related]
19. [Myocardial blood flow and glucose metabolism in patients with myocardial infarction evaluated by positron emission tomography: comparison with left ventriculography]. Fudo T; Kambara H; Hashimoto T; Hayashi M; Kawai C; Senda M; Tamaki N; Yonekura Y J Cardiol; 1988 Mar; 18(1):13-20. PubMed ID: 3265437 [TBL] [Abstract][Full Text] [Related]
20. Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease. Mäki M; Nuutila P; Laine H; Voipio-Pulkki LM; Haaparanta M; Solin O; Knuuti JM Diabetes; 1997 Sep; 46(9):1491-6. PubMed ID: 9287051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]